COMPLETEDNA

Evaluation of the Veriton SPECT/CT System

NCT04722185•Mayo Clinic

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Focus of Study is Comparison of 2 Types of Gamma Cameras

Interventions

Veriton SPECT/CT

Locations

1

United States

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

January 20, 2021

Primary Completion Date

December 31, 2025

Completion Date

December 31, 2025

Last Updated

January 5, 2026

Sponsors

Lead Sponsor

Mayo Clinic

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 5, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions